These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4218871)

  • 1. Pharmacology and physiology of stereotyped behavior.
    Randrup A; Munkvad I
    J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
    [No Abstract]   [Full Text] [Related]  

  • 2. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 3. 6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: effect on amphetamine-induced stereotyped behavior in rats.
    Asher IM; Aghajanian GK
    Brain Res; 1974 Dec; 82(1):1-12. PubMed ID: 4373138
    [No Abstract]   [Full Text] [Related]  

  • 4. The neuroleptics. 5. Animal behavior.
    Buser P; Cook L; Giurgea C; Jacobsen E; Ray OS; Richelle M; Silverman AP; Stein L; Votava Z
    Mod Probl Pharmacopsychiatry; 1970; 5():85-108. PubMed ID: 5005610
    [No Abstract]   [Full Text] [Related]  

  • 5. Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.
    Klawans HL; Margolin DI
    Arch Gen Psychiatry; 1975 Jun; 32(6):725-32. PubMed ID: 1130936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
    Randrup A
    Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.
    Lal H; Gianutsos G; Puri SK
    Life Sci; 1975 Jul; 17(1):29-34. PubMed ID: 238089
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs.
    Groves PM; Rebec GV
    Annu Rev Psychol; 1976; 27():91-127. PubMed ID: 773267
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine and the pharmacology of schizophrenia: the state of the evidence.
    Matthysse S
    J Psychiatr Res; 1974; 11():107-13. PubMed ID: 4218872
    [No Abstract]   [Full Text] [Related]  

  • 10. The neuroleptics. 3. Pharmacology. Introduction.
    Van Rossum JM; Janssen PA; Boissier JR; Julou L; Loew DM; Moller Nielsen I; Munkvad I; Randrup A; Stille G; Tedeschi DH
    Mod Probl Pharmacopsychiatry; 1970; 5():23-32. PubMed ID: 5527165
    [No Abstract]   [Full Text] [Related]  

  • 11. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum.
    Protais P; Costentin J; Schwartz JC
    Psychopharmacology (Berl); 1976 Oct; 50(1):1-6. PubMed ID: 827755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intracisternally administered adenosine and inosine on apomorphine- and amphetamine-induced stereotyped behaviour in rats.
    Singh J
    Indian J Physiol Pharmacol; 1990 Jan; 34(1):45-7. PubMed ID: 2361724
    [No Abstract]   [Full Text] [Related]  

  • 13. The mechanism of action of psychopharmacological agents on behaviour.
    Munkvad I
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 2):21-30. PubMed ID: 805510
    [No Abstract]   [Full Text] [Related]  

  • 14. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
    Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
    J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
    [No Abstract]   [Full Text] [Related]  

  • 15. Amphetamine-induced changes in striatal dopamine and acetylcholine levels and relationship to rotation (circling behavior) in rats.
    Glick SD; Jerussi TP; Water DH; Green JP
    Biochem Pharmacol; 1974 Nov; 23(22):3223-5. PubMed ID: 4474884
    [No Abstract]   [Full Text] [Related]  

  • 16. Modification of apomorphine induced stereotypies in rates by aversive conditioning.
    Gale KN; Murray JP; Horita A
    Proc West Pharmacol Soc; 1975; 18():375-9. PubMed ID: 1237143
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
    Conway PG; Uretsky NJ
    J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
    [No Abstract]   [Full Text] [Related]  

  • 18. The central action of 5-allyl-5-(beta-hydroxypropyl)-N-phenylbarbituric acid and the corresponding lactone.
    Sieroslawska J; Czarnecki R; Sypniewska M; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1973; 25(2):113-26. PubMed ID: 4798099
    [No Abstract]   [Full Text] [Related]  

  • 19. Methodone interaction with apomorphine- and amphetamine-induced turning.
    Stratten WP
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):675-8. PubMed ID: 1237160
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of beta-/Tyr9/melanotropin-/9-18/ on apomorphine-induced stereotyped cage-climbing and on striatal dopamine release in mice. Comparative studies with amphetamine.
    Vécsei L; Telegdy G; Schally AV; Coy DH
    Neuropeptides; 1982 Dec; 3(2):91-6. PubMed ID: 6891751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.